{
  "resourceType": "MedicationAdministration",
  "id": "medadmin0304",
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: completed\u003c/p\u003e\u003ch3\u003eMedications\u003c/h3\u003e\u003ctable\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cp\u003e\u003cb\u003esubject\u003c/b\u003e: \u003ca\u003eDonald Duck. Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eencounter\u003c/b\u003e: \u003ca\u003eencounter who leads to this prescription. Generated Summary: id: v1451 (OFFICIAL); status: completed; \u003cspan\u003eambulatory\u003c/span\u003e; \u003cspan\u003ePatient-initiated encounter\u003c/span\u003e; \u003cspan\u003eNon-urgent cardiological admission\u003c/span\u003e\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eoccurence\u003c/b\u003e: 15 Jan. 2015, 2:30:00 pm --\u0026gt; 16 Jan. 2015, 12:30:00 am\u003c/p\u003e\u003ch3\u003ePerformers\u003c/h3\u003e\u003ctable\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eActor\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003e\u003ca\u003ePatrick Pump. Generated Summary: id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); Phone: 020556936, S.M.Heps@bmc.nl, Fax: 0205669283; gender: female; birthDate: 1971-11-07\u003c/a\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eReasons\u003c/h3\u003e\u003ctable\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003cp\u003e\u003cb\u003erequest\u003c/b\u003e: \u003ca\u003eGenerated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; authoredOn: 2015-01-15\u003c/a\u003e\u003c/p\u003e\u003ch3\u003eDosages\u003c/h3\u003e\u003ctable\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eText\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRoute\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eMethod\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDose\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eRapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk\u003c/td\u003e\u003ctd\u003e\u003cspan\u003eIntravenous route (qualifier value)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u003cspan\u003eInject - dosing instruction imperative (qualifier value)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e3 mg\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/div\u003e"
  },
  "contained": [
    {
      "resourceType": "Medication",
      "id": "med0303",
      "code": {
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1594660",
            "display": "Alemtuzumab 10mg/ml (Lemtrada)"
          }
        ]
      }
    }
  ],
  "status": "completed",
  "medication": {
    "reference": {
      "reference": "#med0303"
    }
  },
  "subject": {
    "reference": "Patient/pat1",
    "display": "Donald Duck"
  },
  "encounter": {
    "reference": "Encounter/f001",
    "display": "encounter who leads to this prescription"
  },
  "occurencePeriod": {
    "start": "2015-01-15T04:30:00+01:00",
    "end": "2015-01-15T14:30:00+01:00"
  },
  "performer": [
    {
      "actor": {
        "reference": "Practitioner/f007",
        "display": "Patrick Pump"
      }
    }
  ],
  "reason": [
    {
      "reference": {
        "reference": "Condition/f202"
      }
    }
  ],
  "request": {
    "reference": "MedicationRequest/medrx0319"
  },
  "dosage": {
    "text": "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
    "route": {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "47625008",
          "display": "Intravenous route (qualifier value)"
        }
      ]
    },
    "method": {
      "coding": [
        {
          "system": "http://snomed.info/sct",
          "code": "422145002",
          "display": "Inject - dosing instruction imperative (qualifier value)"
        }
      ]
    },
    "dose": {
      "value": 3,
      "unit": "mg",
      "system": "http://unitsofmeasure.org",
      "code": "mg"
    }
  },
  "meta": {
    "tag": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST",
        "display": "test health data"
      }
    ]
  }
}